FDA Clears Avastin for Breast Cancer
February 23, 2008 By MATTHEW PERRONE, AP Business Writer(AP) -- A Genentech drug received federal approval on Friday to treat breast cancer, a surprise decision that could represent a shift in standards for assessing the effectiveness of cancer medicines.
Content from The Associated Press expires 15 days after original publication date. For more information about The Associated Press, please visit www.ap.org .
Similar stories from PHYSorg:
Glaxo seeks OK to expand breast cancer drug use
Apr 01, 2009 |
not rated yet |
0
FDA approves cancer treatment for dogs
Jun 03, 2009 |
not rated yet |
0
Novel drug combo improves breast cancer survival
Dec 11, 2009 |
not rated yet |
0
Antibody-guided drug shows encouraging activity in metastatic breast cancer
Dec 12, 2009 |
5 / 5 (1) |
0
Roche to take over Genentech for $47 billion
Mar 12, 2009 |
not rated yet |
0



I think the NBCC needs a new president. "...progression-free survival..." is pretty d**n important when you have cancer.